BHST BIOHARVEST SCIENCES INC.

NEUTRAL Impact: 3/10 6-K
Horizon weeks Filed May 14, 2026 Processed 26d 15h ago SEC 0001723464-26-000026
Notable filing: 6-K
Latest settled — T+5d ⚠ clustered
BHST ▼ -8.17% at T+5d
NEUTRAL call ✗ call lost -8.17% · α vs SPY -7.46% · entry $4.16 → $3.82
Next anchor: T+20d in 2d
Last close $3.12 (close Jun 8) · -25.00% from $4.16 entry
Entry anchored
May 14, 10:06 AM ET
via Databento tick
T+1d
-1.44%
call -1.44% · α -0.22%
$4.10
settled 26d ago
T+5d
-8.17%
call -8.17% · α -7.46%
$3.82
settled 20d ago
T+20d
call — · α —
in 2d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

BioHarvest Sciences appointed Nedira Salzman-Frenkel as VP of Business Development for its CDMO division. The appointment is a routine organizational change with no material financial data disclosed — no revenue, earnings, contract values, or guidance were provided.

Actionable Insight

Monitor for future CDMO contract announcements or revenue guidance updates. This hire alone does not warrant a trading action.

Key Facts

  • Nedira Salzman-Frenkel appointed VP of Business Development for BioHarvest's CDMO division on May 12, 2026.
  • Ms. Salzman-Frenkel previously secured approximately $30 million in CRO contracts at the Salzman Group.
  • No financial terms, revenue targets, or contract values were disclosed in the filing.
  • The filing is a routine business development hire with no material financial impact.

Financial Impact

No financial figures disclosed — appointment is a routine organizational change.

Risk Factors

  • No assurance that new business development will lead to signed contracts or increased revenue.
  • Forward-looking statements caution that increased revenue may not translate to net income or profitability.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (8 analysts)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001723464-26-000026
Document: bhsc_ex991.htm0001723464-26-000026
Document: 0001723464-26-000026-index-headers.html0001723464-26-000026
Document: 0001723464-26-000026-index.html0001723464-26-000026
Document: 0001723464-26-000026.txt0001723464-26-000026
8 reports for BHST
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for BHST — sortable, filterable
Type Now
May 28, 2026
12d ago
6-K
NEUTRAL ★ 3/10
$3.90 $3.56▼ −8.72%▼ −8.67%$3.12 (−20.00%)
May 14, 2026
26d ago
6-K
NEUTRAL ★ 5/10
$4.16 $3.82▼ −8.17%▼ −7.46%$3.12 (−25.00%)
May 14, 2026
26d ago
6-K
BEARISH ★ 6/10
$4.16 $3.82▲ +8.17%▲ +7.46%$3.12 (+25.00%)
May 14, 2026
26d ago
6-K
NEUTRAL ★ 3/10
$4.16 $3.82▼ −8.17%▼ −7.46%$3.12 (−25.00%)
May 12, 2026
28d ago
6-K
NEUTRAL ★ 4/10
$3.84 $3.96▲ +3.13%▲ +3.05%$3.12 (−18.75%)
May 11, 2026
29d ago
6-K
NEUTRAL ★ 2/10
$3.84 $3.96▲ +3.13%▲ +3.05%$3.12 (−18.75%)
Apr 29, 2026
5w ago
6-K
NEUTRAL ★ 3/10
$4.25 $4.21▼ −0.94%▼ −4.05%$3.12 (−26.59%)
Mar 27, 2026
10w ago
6-K
BULLISH ★ 7/10
$4.32 $4.36▲ +0.93%▼ −2.94%$3.12 (−27.78%)
Showing 8 of 8

US Market Status

Market Closed — Opens in 7h 18m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access